Research Shows Access to Health Insurance Invaluable in Early Cancer Diagnosis – InsuranceNewsNet


Cancer is the second commonest reason behind death in america, affecting nearly two million people yearly and taking greater than one-half one million lives every yr. Almost one-half of the people that suffer from cancer are diagnosed with the deadly condition late.

Most of the time, late-stage diagnoses significantly limit the effectiveness of treatment and…

Read More>>

NOTE TO INVESTORS: The newest news and updates referring to QSAM Biosciences Inc. (OTCQB: QSAM) can be found in the corporate’s newsroom at

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that gives (1) access to a network of wire services via InvestorWire to succeed in all goal markets, industries and demographics in essentially the most effective manner possible, (2) article and editorial syndication to five,000+ news outlets (3), enhanced press release services to make sure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to almost 2 million followers, (5) a full array of corporate communications solutions, and (6) a complete news coverage solution with BMW Prime. As a multifaceted organization with an intensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public firms that desire to succeed in a large audience of investors, consumers, journalists and most of the people. By cutting through the overload of data in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and knowledge converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published:

BioMedWire (BMW)
San Francisco, California
415.949.5050 Office
[email protected]

BioMedWire is an element of the InvestorBrandNetwork.


Please enter your comment!
Please enter your name here